| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.009 |